BCYC Stock Analysis: Buy, Sell, or Hold?
BCYC - Bicycle Therapeutics plc American Depositary Shares
$6.42
-0.10 (-1.53%)
▼
HOLD
LOW Confidence
Last Updated: January 30, 2026
Earnings: Feb 24, 2026
22d
Get Alerted When BCYC Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: BCYC shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: BCYC shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: BCYC is currently trading at $6.42, which is considered oversold relative to its 30-day fair value range of $6.52 to $6.95.
Technical Outlook: Technically, BCYC is in a downtrend. Immediate support is located at $6.22, while resistance sits at $7.34.
Market Sentiment: BCYC has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $21.50 (+234.9%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, BCYC is in a downtrend. Immediate support is located at $6.22, while resistance sits at $7.34.
Market Sentiment: BCYC has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $21.50 (+234.9%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$6.52 -
$6.95
Company Quality Score
42/100
(HOLD)
Options IV Signal
50th percentile
(NORMAL)
Volume Confirmation
HIGH
Confidence Score
60.4%
Protect Your Profits
Holding BCYC? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Options fairly priced (IV 50th percentile)
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 234.9% below Wall St target ($21.50)
- CAUTION: Recommendation downgraded due to -7.6% 5-day decline
Fair Price Analysis
30-Day Fair Range
$6.52 -
$6.95
Current vs Fair Value
OVERSOLD
Expected Move (7 Days)
±$0.79
(12.3%)
Support & Resistance Levels
Support Level
$6.22
Resistance Level
$7.34
Current Trend
Downtrend
Fundamental Context
Forward P/E (Next Year Est.)
-1.84
Wall Street Target
$21.50
(+234.9%)
Revenue Growth (YoY)
338.5%
Last updated: February 01, 2026 8:03 AM ET
Data refreshes hourly during market hours. Next update: 9:03 AM
Data refreshes hourly during market hours. Next update: 9:03 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is BCYC showing a specific setup today?
Insider Activity (6 Months)
0
Buys
8
Sells
Net
INSIDERS SELLING
Recent Transactions
Kevin Lee
SELL
3231 shares
2025-10-03
Travis Alvin Thompson
SELL
103 shares
2025-10-03
Alistair Milnes
SELL
978 shares
2025-10-03
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ONC
BeiGene, Ltd. |
STRONG BUY
24 analysts |
$404 | 63 BUY |
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$56 | 59 HOLD |
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
19 analysts |
$210 | 57 HOLD |
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
19 analysts |
$93 | 56 HOLD |
|
RCKT
Rocket Pharmaceuticals I… |
STRONG BUY
18 analysts |
$8 | 53 HOLD |
Advanced BCYC Option Strategies
Professional options setups generated by AI based on today's BCYC price and gamma walls.
